Booth 601
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on Twitter.
Booth 101
Description: GammaTile is FDA-cleared to treat operable brain tumors including newly diagnosed malignant and recurrent brain tumors. Implanted during brain tumor resection, GammaTile uses collagen tiles that are embedded with radiation sources providing an immediate, dose-intense treatment to eliminate residual tumor cells. This "one and done" procedure allows patients to receive radiation while going about their daily lives, requiring no additional trips to the hospital or clinic for radiation therapy.
Booth 319/418
Theragenics partners with physicians, healthcare providers, and medical associations to deliver effective cancer treatments to patients worldwide. Our brachytherapy portfolio includes the industry leading TheraSeed® Palladium-103 seed and AgX100® Iodine-125 seed, both sourced and manufactured within North America.
As a brachytherapy pioneer, Theragenics is known for delivering quality seeds, strands, pre-loaded needles, and carriers, all with personalized service. And because we’re committed to providing effective, minimally invasive treatment options with minimal side effects, we continue to invest in this space. For more information, please visit www.theragenics.com.
Booth 301
At Varian, a Siemens Healthineers company, we are working to create a world without fear of cancer. For more than 70 years, we have developed, built, and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning, and data analytics to address and enhance the entire cancer care journey and expand access to care. To learn more about our solutions, go to http://www.varian.com.
Booth 403/402
Best Medical International (BMI), a TeamBest Global company, encompasses a family of trusted organizations and companies that specialize in providing innovative, high-quality, and efficient solutions for brachytherapy, vascular brachytherapy, and external beam radiation therapy. BMI manufactures and supplies Iodine-125 and Palladium-103 seeds, needles, templates, applicators, catheters, fiducial markers, dosimeter systems, the NovosteTM Beta-CathTM System, and a variety of other products for brachytherapy and other radiation therapy applications. Additionally, BMI and other TeamBest companies manufacture a wide range of products such as cyclotrons for medical isotopes production, GammaBeam teletherapy systems, blood irradiators, particle therapy accelerators, AccuBoost system, QA/QC instruments and ultrasound imaging systems. Our goal is to become the go-to partner for clinicians who seek all their radiation therapy and oncology product and service requirements.
Booth 119/218
CQ Medical is the global leader in developing high-quality, innovative, patient-centric radiotherapy and cancer therapy solutions. Our company has more than 80 years of combined experience bringing to market advanced hardware and consumables for patient immobilization and positioning and patient care products, including the Symphony® Patient Transport System that revolutionized the movement of patients between procedural, imaging, and treatment modalities for HDR brachytherapy workflows.
Booth 305
BioProtect is a technology platform company that provides innovative biodegradable spacing solutions. Currently commercially available is our BioProtect Balloon, which addresses radiation-induced rectal toxicity in prostate cancer patients.
Our vision is to become a world leader in spacing technology and to protect healthy organs during radiation therapy treatment.
BioProtect’s first application, the BioProtect Balloon Implant System, is commercially available in Europe and in the US.
BioProtect is ISO 13485:2016 certified, FDA cleared, and CE marked.
.png){kind=logo}
Booth 202
At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types.
Tabletop 4
C4 Imaging pioneers cutting-edge MRI-positive signal markers, revolutionizing precision treatment planning and cancer therapy. Their flagship innovation, NOVA, stands alone as the premier MRI-positive signal fiducial marker, delivering precise daily treatment alignment, reduced dose perturbation, and pinpoint tumor localization for focal therapy.
